Tingxuan Lv

Weifang Medical University

Papers

1

Total Citations

1

H-Index

1

About

Tingxuan Lv is a rising researcher in urologic oncology, with a focused expertise in surgical techniques for prostate cancer. Their major contribution lies in advancing the understanding of nerve-sparing procedures during robot-assisted radical prostatectomy. Specifically, Lv’s most-cited work, a 2025 systematic review and meta-analysis, critically compares neurovascular structure-adjacent frozen-section examination (NeuroSAFE) against standard techniques. This study synthesizes evidence from two-arm comparative trials to evaluate functional outcomes—such as potency and continence—alongside oncological control, highlighting a pivotal shift toward personalized, tissue-preserving surgery. While still early in their career, with 1 citation on this landmark paper, Lv’s work is already shaping clinical decision-making by providing a rigorous evidence base for intraoperative pathology guidance. Their research underscores a commitment to balancing cancer eradication with quality of life, a central challenge in modern urology. As the field moves toward precision surgery, Lv’s meta-analysis serves as a foundational reference for surgeons and researchers alike, promising to influence future trials and guidelines. With this impactful debut, Tingxuan Lv is a name to watch in the evolving landscape of robotic prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Neurovascular structure-adjacent frozen-section examination vs. standard robot-assisted radical prostatectomy: a systematic review and meta-analysis of two-arm comparative studies on functional and oncological outcomes
1 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Weifang Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago